AzTrials
AzTrials

StrokeNCT03619772

EMG Training for Altering Activation Patterns After Stroke

A study testing Bilateral and Unilateral in people with Stroke and Weakness, Muscle, run by Shirley Ryan AbilityLab at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluation of a new EMG controlled game to improve hand function in chronic stroke survivors. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke, Weakness, Muscle, Coordination Lack
What is being tested?
Bilateral and Unilateral
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
28 Jun 2018to 1 Jul 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Single, unilateral stroke at least 6 months prior to enrollment
  • Moderate hand impairment defined by Stage 4 or Stage 5 on the Chedoke McMaster Stroke Assessment Scale

Who cannot join

  • Visual neglect or deficits (with inability to compensate)
  • Upper extremity orthopedic conditions that interfere with movement
  • Cerebellar stroke
  • Children, prisoners, or adult unable to provide consent will not be recruited. As the procedures pose no increased risk for pregnant women, we will not specifically exclude them.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Shirley Ryan AbilityLab

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: Altering Activation Patterns With EMG Training in the Distal Upper Extremity After Stroke

Evaluation of a new EMG controlled game to improve hand function in chronic stroke survivors.

Read the detailed description

Increased impairment of the hand is commonly reported as an outcome occurring after a stroke. This impairment is due mainly to the decreased ability to modulate appropriate muscle activation patterns. Issues with appropriately modifying activation patterns can profoundly affect tasks of daily living. This study is evaluating a novel software focusing on retraining hand muscle activation patterns through an Electromyographic (EMG) controlled game. Stroke survivors with chronic, severe hemiparesis of the hand will participate in a longitudinal study consisting of 3 weeks of training. We hypothesize that stroke survivors will experience a decrease in time to complete a test of EMG control, as well as improvement in hand motor control.

Being tested
Bilateral, Unilateral
Keywords
hand, stroke, therapy, rehabilitation
Medical subject headings
Stroke, Muscle Weakness, Ataxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BilateralOther

    Participants will control game using EMG from both upper limbs.

  • UnilateralOther

    Participants will control game using EMG from the more impaired upper limb.

Study groups in NCT03619772
Study groupRoleWhat they receive
BilateralExperimentalParticipants will control game using EMG from both upper limbs.
Receives: Other: Bilateral
UnilateralActive comparatorParticipants will control game using the more impaired upper limb.
Receives: Other: Unilateral

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Mean Completion Time for Timed Test

    Time to complete movement to 16 randomized targets

    Measured: Baseline and 3 weeks (immediately post intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2018
  2. Study start28 Jun 2018
  3. Primary completion31 Oct 2020
  4. Study completion1 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03619772
Sponsor's protocol ID
STU00206747
Other IDs
R01HD075813
Status last verified
Oct 2023
First submitted
3 Aug 2018
Last updated
20 Mar 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Seo NJ, Barry A, Ghassemi M, Triandafilou KM, Stoykov ME, Vidakovic L, Roth E, Kamper DG. Use of an EMG-Controlled Game as a Therapeutic Tool to Retrain Hand Muscle Activation Patterns Following Stroke: A Pilot Study. J Neurol Phys Ther. 2022 Jul 1;46(3):198-205. doi: 10.1097/NPT.0000000000000398. Epub 2022 Mar 22.

    PubMed 35320135

Questions about this trial

What is this clinical trial studying?

A study testing Bilateral and Unilateral in people with Stroke and Weakness, Muscle, run by Shirley Ryan AbilityLab at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Mar 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Mean Completion Time for Timed Test (time frame: Baseline and 3 weeks (immediately post intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03619772, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03619772 | AzTrials